95
Views
11
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

&
Pages 351-355 | Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pietro Gareri, Cristina Segura-García, Valeria Graziella Laura Manfredi, Antonella Bruni, Paola Ciambrone, Gregorio Cerminara, Giovambattista De Sarro & Pasquale De Fazio. (2014) Use of atypical antipsychotics in the elderly: a clinical review. Clinical Interventions in Aging 9, pages 1363-1373.
Read now
L Annemans, I Eijgelshoven, A Smet, A Jacobs & G Bergman. (2012) THE IMPACT OF TREATMENT WITH RISPERIDONE LONG-ACTING INJECTION ON THE BELGIAN HEALTHCARE SYSTEM: RESULTS FROM A BUDGET IMPACT MODEL. Acta Clinica Belgica 67:2, pages 108-119.
Read now
Wissam El-Hage & Simon A Surguladze. (2010) Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection. Neuropsychiatric Disease and Treatment 6, pages 455-464.
Read now

Articles from other publishers (8)

Barnita Saha, Isha Gupta, Surabhi Dayal & Sonia Chhabra. (2021) A rare case of risperidone induced reticular palmar pigmentation. Indian Dermatology Online Journal 12:1, pages 183.
Crossref
Abdollah Amini, Zahra Namvarpour, Mozhdeh Namvarpour & Amir Raoofi. (2020) Risperidone accelerates bone loss in rats with autistic-like deficits induced by maternal lipopolysaccharides exposure. Life Sciences 258, pages 118197.
Crossref
Priya Janardhana, Anil KumarMysore Nagaraj & PL Basavanna. (2016) Risperidone-induced skin rash. Indian Journal of Psychiatry 58:1, pages 106.
Crossref
Benno G. Schimmelmann, Peter Falkai & Hans Förstl. 2016. Praxishandbuch Schizophrenie. Praxishandbuch Schizophrenie 61 74 .
Ahsan Y. Khan, William Redden, Muhammad Ovais & George T. Grossberg. (2015) Current Concepts in the Diagnosis and Treatment of Schizophrenia in Later Life. Current Geriatrics Reports 4:4, pages 290-300.
Crossref
Natasa Petronijevic, Jelena Sopta, Mirjana Doknic, Nevena Radonjic, Milan Petronijevic, Sandra Pekic, Nadja Maric, Miroslava Jasovic-Gasic & Vera Popovic. (2013) Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 46, pages 58-63.
Crossref
Dhiren Singh & Owen Williams. (2012) A change from risperidone long acting injection to paliperidone palmitate in an elderly patient – a cautionary tale. Australian & New Zealand Journal of Psychiatry 46:2, pages 176-177.
Crossref
Rosa CatalánRafael Penadés. (2011) Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia. Journal of Central Nervous System Disease 3, pages JCNSD.S4125.
Crossref